IT8748469A0 - Composizioni farmaceutiche a cessione ritardata - Google Patents

Composizioni farmaceutiche a cessione ritardata

Info

Publication number
IT8748469A0
IT8748469A0 IT8748469A IT4846987A IT8748469A0 IT 8748469 A0 IT8748469 A0 IT 8748469A0 IT 8748469 A IT8748469 A IT 8748469A IT 4846987 A IT4846987 A IT 4846987A IT 8748469 A0 IT8748469 A0 IT 8748469A0
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
delayed release
release pharmaceutical
delayed
compositions
Prior art date
Application number
IT8748469A
Other languages
English (en)
Other versions
IT1221493B (it
Inventor
Henry C Gan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8748469A0 publication Critical patent/IT8748469A0/it
Application granted granted Critical
Publication of IT1221493B publication Critical patent/IT1221493B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
IT48469/87A 1986-10-09 1987-10-08 Composizioni farmaceutiche a cessione ritardata IT1221493B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IT8748469A0 true IT8748469A0 (it) 1987-10-08
IT1221493B IT1221493B (it) 1990-07-06

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48469/87A IT1221493B (it) 1986-10-09 1987-10-08 Composizioni farmaceutiche a cessione ritardata

Country Status (24)

Country Link
JP (1) JPS63101334A (it)
KR (1) KR880004801A (it)
AU (1) AU7942087A (it)
BE (1) BE1000732A5 (it)
CA (1) CA1332809C (it)
CH (1) CH675831A5 (it)
DE (1) DE3733540A1 (it)
DK (1) DK527487A (it)
ES (1) ES2014518A6 (it)
FI (1) FI874414A (it)
FR (1) FR2604902B1 (it)
GB (2) GB8624213D0 (it)
GR (1) GR871550B (it)
HU (1) HU201875B (it)
IL (1) IL84104A0 (it)
IT (1) IT1221493B (it)
LU (1) LU87009A1 (it)
NL (1) NL8702294A (it)
NO (1) NO874200L (it)
NZ (1) NZ222083A (it)
PH (1) PH24227A (it)
PT (1) PT85880B (it)
SE (1) SE8703889L (it)
ZA (1) ZA877617B (it)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
NZ514890A (en) 1999-03-31 2003-05-30 Janssen Pharmaceutica Nv Pregelatinized starch in a controlled release formulation
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
ES2330227T3 (es) * 2004-09-09 2009-12-07 Psicofarma, S.A. De C.V. Composicion farmaceutica de liberacion prolongada de hidralazina y su uso como apoyo para el tratamiento de cancer.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
CA1332809C (en) 1994-11-01
GB8624213D0 (en) 1986-11-12
BE1000732A5 (fr) 1989-03-21
AU7942087A (en) 1988-04-14
PT85880B (pt) 1990-07-31
DK527487A (da) 1988-04-10
NO874200D0 (no) 1987-10-07
GB8723515D0 (en) 1987-11-11
HUT52958A (en) 1990-09-28
FI874414A (fi) 1988-04-10
PH24227A (en) 1990-05-04
SE8703889D0 (sv) 1987-10-08
GR871550B (en) 1988-02-15
NO874200L (no) 1988-04-11
PT85880A (en) 1987-11-01
NL8702294A (nl) 1988-05-02
FI874414A0 (fi) 1987-10-07
HU201875B (en) 1991-01-28
SE8703889L (sv) 1988-04-10
GB2195893B (en) 1991-05-08
FR2604902B1 (fr) 1991-04-26
JPS63101334A (ja) 1988-05-06
ZA877617B (en) 1989-05-30
FR2604902A1 (fr) 1988-04-15
LU87009A1 (fr) 1988-05-03
DE3733540A1 (de) 1988-04-14
IT1221493B (it) 1990-07-06
ES2014518A6 (es) 1990-07-16
CH675831A5 (it) 1990-11-15
KR880004801A (ko) 1988-06-27
GB2195893A (en) 1988-04-20
NZ222083A (en) 1991-05-28
DK527487D0 (da) 1987-10-08
IL84104A0 (en) 1988-03-31

Similar Documents

Publication Publication Date Title
SE8801813D0 (sv) Pharmaceutical composition
KR890701101A (ko) 제약학적 조성물
DK489189D0 (da) Farmaceutisk praeparat
DK705488A (da) Farmaceutisk praeparat
DK48090D0 (da) Kapselpraeparat
IT1216822B (it) Composizioni farmaceutiche a basedi chetotifene
IT8748469A0 (it) Composizioni farmaceutiche a cessione ritardata
DK603988D0 (da) Farmaceutisk praeparat
DK336489D0 (da) Farmaceutisk praeparat
DK139388D0 (da) Farmaceutisk praeparat
MX11584A (es) Composiciones farmaceuticas
IT1216814B (it) Composizioni farmaceutiche
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK138888A (da) Farmaceutisk praeparat
IT8721670A0 (it) Composizioni farmaceutiche a basedi ottreotide.
IT1221509B (it) Composizione farmaceutica contenente un derivato benzodiazepinico
DK638889A (da) Farmaceutisk kombinationspraeparat
LV5728A4 (lv) Farmaceitiskas kompozicijas
LV5734A4 (lv) Farmaceitiskas kompozicijas
GB8624214D0 (en) Sustained release pharmaceutical compositions
SE8602975D0 (sv) Farmaceutisk beredning
SE8603912D0 (sv) Farmaceutisk beredning
SE8700576D0 (sv) Pharmaceutical composition
SE8705100D0 (sv) Farmaceutisk komposition
DK408189D0 (da) Farmaceutisk praeparat